Sunday, April 21, 2024 8:12:08 PM
Recent PRME News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/05/2026 05:15:13 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/03/2026 01:41:10 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 03/03/2026 01:32:23 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/03/2026 01:19:51 PM
- Form POSASR - Post-effective Amendment to an automatic shelf registration statement • Edgar (US Regulatory) • 03/03/2026 01:13:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 01:02:09 PM
- Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 03/03/2026 01:00:00 PM
- Prime Medicine to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/25/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 01:31:26 PM
- Prime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/07/2026 01:00:00 PM
- Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize • PR Newswire (US) • 01/02/2026 06:29:00 PM
- Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize • PR Newswire (Canada) • 01/02/2026 06:29:00 PM
- Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease • GlobeNewswire Inc. • 12/07/2025 01:05:00 PM
- Prime Medicine to Present at 8th Annual Evercore Healthcare Conference • GlobeNewswire Inc. • 11/25/2025 01:00:00 PM
- Prime Medicine to Present at Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 11/11/2025 01:00:00 PM
- CORRECTION - Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 11/07/2025 03:21:45 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 11/07/2025 01:05:14 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2025 12:35:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2025 12:27:06 PM
- Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 11/07/2025 12:00:00 PM
- Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer • GlobeNewswire Inc. • 11/03/2025 01:01:00 PM
- Prime Medicine to Host Virtual KOL Event to Showcase Wilson’s Disease Strategy • GlobeNewswire Inc. • 10/30/2025 08:01:00 PM
- Prime Medicine to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 10/07/2025 12:00:00 PM
FEATURED Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
